12
appointment
Day 1, Day 3, Day 7, Day 30, Day 33, Day 37, Day 60, Day 180, Day 183, Day 187, Day 210, Day 360
You are reading:
Healthy Participants
|
The Meningococcal B Vaccine Study
Healthy Participants
The Meningococcal B Vaccine Study
Start date
Coming soon
Renumeration
$6,000
12 appointments
Help Test a New Vaccine for the Prevention of Meningococcal Disease
This clinical study is evaluating a new vaccine the Prevention of Meningococcal Disease. The primary goal is to assess the safety and tolerability of the treatment in healthy adult participants.
Example Schedule
To Qualify, You Must
Age
Be 18 to 50 years old
Gender
Both males or females
Physical Condition
Have no significant medical health conditions or allergies
Requirements
Have a BMI between 18 and 32kg/m2
Renumeration
$6,000 *Screening Reimbursement of $100–$250 applies, please see Terms
Help Test a New Vaccine for the Prevention of Meningococcal Disease
Spots are limited. Find out if you qualify today!
Close
Not sure yet? Keep me updated on paid clinical trials at Linear
Get notified about the latest trials each month and find one that fits your interests and schedule.
"*" indicates required fields